Top

Cancer Chemotherapy and Pharmacology

Published in:

01-01-2014 | Original Article

The effect of chemotherapy with cisplatin and pemetrexed for choroidal metastasis of non-squamous cell carcinoma

Authors: Chih-Jen Yang, Ying-Ming Tsai, Ming-Ju Tsai, Hsu-Liang Chang, Ming-Shyan Huang

Published in: Cancer Chemotherapy and Pharmacology | Issue 1/2014

Abstract

Purpose

Choroidal metastasis from lung cancer is very rare in the clinical setting. Treatment for lung cancer with symptomatic choroidal metastasis remains uncertain because of the rarity of such cases.

Methods

We performed a retrospective study on symptomatic choroidal metastasis from lung cancer at the Kaohsiung Medical University Hospital from January 2010 to August 2011. In addition, we also performed literature review of all such patients (or of cancers with choroidal metastasis) treated with systemic chemotherapy.

Results

In our study, a total of 226 lung cancer patients were registered during the study period, and only four had choroidal metastasis (4/226, 1.77 %). Three were female (75 %) and one was male, with a mean age of 40.74 (range 26–60) years. Three patients had marked choroidal tumor regression after treatment with pemetrexed and cisplatin. In the literature reviews, there are only 12 patients (including our patients) received systemic chemotherapy alone instead of local therapy and eight (66.7 %) demonstrated choroidal tumor regression after treatment.

Conclusions

Symptomatic choroidal metastasis from lung cancer is extremely rare. Our findings indicate that systemic chemotherapy with pemetrexed and cisplatin may be a good option for such patients. Further large-scale studies for the treatment of such patients are warranted. However, currently, radiotherapy is still the gold standard for such patients.

Postmus PE, Brambilla E, Chansky K et al (2007) The IASLC lung cancer staging project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2:686–693PubMedCrossRef

Kreusel KM, Bechrakis NE, Wiegel T et al (2008) Incidence and clinical characteristics of symptomatic choroidal metastasis from lung cancer. Acta Ophthalmol 86:515–519PubMedCrossRef

Herrag M, Lahmiti S, Yazidi AA et al (2010) Choroidal metastasis revealing a lung adenocarcinoma. Ann Thorac Surg 89:1013–1014PubMedCrossRef

John VJ, Jacobson MS, Grossniklaus HE (2010) Bilateral choroidal metastasis as the presenting sign of small cell lung carcinoma. J Thorac Oncol 5:1289PubMedCentralPubMedCrossRef

Kim SW, Kim MJ, Huh K et al (2009) Complete regression of choroidal metastasis secondary to non-small-cell lung cancer with intravitreal bevacizumab and oral erlotinib combination therapy. Ophthalmologica 223:411–413PubMedCrossRef

Singh A, Singh P, Sahni K et al (2010) Non-small cell lung cancer presenting with choroidal metastasis as first sign and showing good response to chemotherapy alone: a case report. J Med Case Rep 4:185PubMedCentralPubMedCrossRef

Okuma Y, Hosomi Y, Kitamura K et al (2009) Choroidal metastasis in a patient with small cell lung cancer discovered during treatment with chemotherapy. Int J Clin Oncol 14:541–544PubMedCrossRef

Chen CJ, McCoy AN, Brahmer J et al (2011) Emerging treatments for choroidal metastases. Surv Ophthalmol 56:511–521PubMedCrossRef

Amer R, Pe’er J, Chowers I et al (2004) Treatment options in the management of choroidal metastases. Ophthalmologica 218:372–377PubMedCrossRef

10.

Rosset A, Zografos L, Coucke P et al (1998) Radiotherapy of choroidal metastases. Radiother Oncol 46:263–268PubMedCrossRef

11.

Mauget-Faysse M, Gambrelle J, Quaranta-El MM et al (2006) Photodynamic therapy for choroidal metastasis from lung adenocarcinoma. Acta Ophthalmol Scand 84:552–554PubMedCrossRef

12.

Wiegel T, Bottke D, Kreusel KM et al (2002) External beam radiotherapy of choroidal metastases–final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol 64:13–18PubMedCrossRef

13.

Asteriou C, Konstantinou D, Kleontas A et al (2010) Blurred vision due to choroidal metastasis as the first manifestation of lung cancer: a case report. World J Surg Oncol 8:2PubMedCentralPubMedCrossRef

14.

Inoue M, Watanabe Y, Yamane S et al (2010) Choroidal metastasis with adenocarcinoma of the lung treated with gefitinib. Eur J Ophthalmol 20:963–965PubMed

15.

Singh N, Kulkarni P, Aggarwal AN et al (2012) Choroidal metastasis as a presenting manifestation of lung cancer: a report of 3 cases and systematic review of the literature. Medicine (Baltimore) 91:179–194CrossRef

16.

George B, Wirostko WJ, Connor TB et al (2009) Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. J Thorac Oncol 4:661–662PubMedCrossRef

17.

Harino S, Miyamoto K, Okada M et al (1995) Indocyanine green videoangiographic findings in choroidal metastatic tumor. Graefes Arch Clin Exp Ophthalmol 233:339–346PubMedCrossRef

18.

Hasturk S, Soylu M, Zeren EH et al (2001) Basaloid large cell lung carcinoma presenting concurrently with metastatic uveal tumor. Lung Cancer 32:95–101PubMedCrossRef

19.

Ascaso FJ, Castillo JM, Garcia FJ et al (2009) Bilateral choroidal metastases revealing an advanced non-small cell lung cancer. Ann Thorac Surg 88:1013–1015PubMedCrossRef

20.

Shields JA, Perez N, Shields CL et al (2002) Simultaneous choroidal and brain metastasis as initial manifestations of lung cancer. Ophthalmic Surg Lasers 33:323–325PubMed

21.

Fujiu K, Kobayashi N, Miyamoto H et al (2012) A case of choroidal metastasis of lung cancer successfully treated with erlotinib. Gan To Kagaku Ryoho 39:269–271PubMed

22.

De PP (1998) Ocular manifestations of cancer. Curr Opin Ophthalmol 9:100–104CrossRef

23.

Freedman MI, Folk JC (1987) Metastatic tumors to the eye and orbit. Patient survival and clinical characteristics. Arch Ophthalmol 105:1215–1219PubMedCrossRef

24.

Kanthan GL, Jayamohan J, Yip D et al (2007) Management of metastatic carcinoma of the uveal tract: an evidence-based analysis. Clin Experiment Ophthalmol 35:553–565PubMedCrossRef

25.

Wang TJ, Yang CM, Ho TC et al (2005) Metastatic choroidal tumors in Taiwan: an 11-year experience. Am J Ophthalmol 140:735–737PubMedCrossRef

26.

Kreusel KM, Wiegel T, Stange M et al (2002) Choroidal metastasis in disseminated lung cancer: frequency and risk factors. Am J Ophthalmol 134:445–447PubMedCrossRef

27.

Shields JA, Shields CL, Eagle RC et al (2004) Lung cancer presenting as vitreous hemorrhage from choroidal metastasis. Retina 24:168–170PubMedCrossRef

28.

Abundo RE, Orenic CJ, Anderson SF et al (1997) Choroidal metastases resulting from carcinoma of the lung. J Am Optom Assoc 68:95–108PubMed

29.

Arevalo JF, Fernandez CF, Garcia RA (2005) Optical coherence tomography characteristics of choroidal metastasis. Ophthalmology 112:1612–1619PubMedCrossRef

30.

Chong JT, Mick A (2005) Choroidal metastasis: case reports and review of the literature. Optometry 76:293–301PubMedCrossRef

31.

Kiratli H, Kiratli PO, Ercan MT (1998) Scintigraphic evaluation of tumors metastatic to the choroid using technetium-99 m(V)-dimercaptosuccinic acid. Jpn J Ophthalmol 42:60–65PubMedCrossRef

32.

Scagliotti GV, Parikh P, von Pawel J et al (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26:3543–3551PubMedCrossRef

Title: The effect of chemotherapy with cisplatin and pemetrexed for choroidal metastasis of non-squamous cell carcinoma
Authors: Chih-Jen Yang
Ying-Ming Tsai
Ming-Ju Tsai
Hsu-Liang Chang
Ming-Shyan Huang
Publication date: 01-01-2014
Publisher: Springer Berlin Heidelberg
Published in: Cancer Chemotherapy and Pharmacology / Issue 1/2014
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI: https://doi.org/10.1007/s00280-013-2341-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients

Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies

Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer

Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer